Brief: Onxeo Secures $7.5 Million Of Non-Dilutive Capital From Swk Holdings Corporation

Valerio Therapeutics SA

07/06/2018 06:42

June 7 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO SECURES $7.5 MILLION OF NON-DILUTIVE CAPITAL FROM
SWK
HOLDINGS CORPORATION THROUGH SALE OF RIGHTS RELATED TO FUTURE
BELEODAQ® ROYALTIES
    * PROCEEDS WILL BE FULLY ALLOCATED TO ADVANCEMENT OF ONXEO'S
PIPELINE, INCLUDING ITS LEAD PRODUCT CANDIDATE, ASIDNA™
    * SALE OF BONDS ENTITLING SWK HOLDINGS CORPORATION TO
RECEIVE
$13.5 MILLION OF FUTURE ROYALTIES AND MILESTONES ON SALES OF
BELEODAQ
    * SALES OF BONDS ENTITLING SWK HOLDINGS CORPORATION TO
RECEIVE
$13.5 MILLION OF FUTURE ROYALTIES, MILESTONES ON SALES OF
BELEODAQ

Source text for Eikon:  ID:nNDLcgxTm1 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom:)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))